Correlation Between Hyundai Engineering and AptaBio Therapeutics
Can any of the company-specific risk be diversified away by investing in both Hyundai Engineering and AptaBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hyundai Engineering and AptaBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hyundai Engineering Plastics and AptaBio Therapeutics, you can compare the effects of market volatilities on Hyundai Engineering and AptaBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hyundai Engineering with a short position of AptaBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hyundai Engineering and AptaBio Therapeutics.
Diversification Opportunities for Hyundai Engineering and AptaBio Therapeutics
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Hyundai and AptaBio is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Hyundai Engineering Plastics and AptaBio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AptaBio Therapeutics and Hyundai Engineering is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hyundai Engineering Plastics are associated (or correlated) with AptaBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AptaBio Therapeutics has no effect on the direction of Hyundai Engineering i.e., Hyundai Engineering and AptaBio Therapeutics go up and down completely randomly.
Pair Corralation between Hyundai Engineering and AptaBio Therapeutics
Assuming the 90 days trading horizon Hyundai Engineering Plastics is expected to under-perform the AptaBio Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Hyundai Engineering Plastics is 2.66 times less risky than AptaBio Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The AptaBio Therapeutics is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 805,000 in AptaBio Therapeutics on August 25, 2024 and sell it today you would lose (177,000) from holding AptaBio Therapeutics or give up 21.99% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hyundai Engineering Plastics vs. AptaBio Therapeutics
Performance |
| Timeline |
| Hyundai Engineering |
| AptaBio Therapeutics |
Hyundai Engineering and AptaBio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hyundai Engineering and AptaBio Therapeutics
The main advantage of trading using opposite Hyundai Engineering and AptaBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hyundai Engineering position performs unexpectedly, AptaBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptaBio Therapeutics will offset losses from the drop in AptaBio Therapeutics' long position.| Hyundai Engineering vs. AptaBio Therapeutics | Hyundai Engineering vs. Daewoo SBI SPAC | Hyundai Engineering vs. Dream Security co | Hyundai Engineering vs. Microfriend |
| AptaBio Therapeutics vs. ABL Bio | AptaBio Therapeutics vs. Helixmith Co | AptaBio Therapeutics vs. OliX PharmaceuticalsInc | AptaBio Therapeutics vs. Oscotec |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |